Occlutech to pay AGA €2.1m in damages
This article was originally published in Clinica
AGA Medical, a manufacturer of devices for treating structural heart defects, has won €2.1m ($2.6m) damages in its four-year dispute with German rival Occlutech. The award was the full amount which Minneapolis, Minnesota-based AGA was seeking. While the verdict is subject to appeal, AGA said it has the right to enforce the decision immediately.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.